Uscom Ltd (UCM) - Cash Flow Conversion Efficiency

Latest as of December 2025: -7.065x

Based on the latest financial reports, Uscom Ltd (UCM) has a cash flow conversion efficiency ratio of -7.065x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.29 Million ≈ $-913.86K USD) by net assets (AU$182.80K ≈ $129.34K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Uscom Ltd (UCM) defensive interval to measure how many days the company can operate on defensive assets alone.

Uscom Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Uscom Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Uscom Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Uscom Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Vp plc
LSE:VP
0.245x
Crest Nicholson Holdings plc
LSE:CRST
0.080x
Magle Chemoswed Holding Ab
ST:MAGLE
-0.006x
UIL Ltd
LSE:UTL
0.057x
Grand Gulf Energy Ltd
AU:GGE
-0.003x
Global Health Ltd
AU:GLH
0.017x
Chesterfield Resources PLC
LSE:CHF
-0.295x
CCSC Technology International Holdings Limited Ordinary Shares
NASDAQ:CCTG
-0.041x

Annual Cash Flow Conversion Efficiency for Uscom Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of Uscom Ltd from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Uscom Ltd market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$-38.22K
≈ $-27.05K
AU$-2.71 Million
≈ $-1.92 Million
70.897x +18753.99%
2024-06-30 AU$3.06 Million
≈ $2.17 Million
AU$-1.16 Million
≈ $-823.17K
-0.380x +18.76%
2023-06-30 AU$3.04 Million
≈ $2.15 Million
AU$-1.42 Million
≈ $-1.01 Million
-0.468x -186.98%
2022-06-30 AU$5.94 Million
≈ $4.20 Million
AU$-967.51K
≈ $-684.58K
-0.163x -1012.52%
2021-06-30 AU$3.08 Million
≈ $2.18 Million
AU$54.98K
≈ $38.90K
0.018x +121.59%
2020-06-30 AU$3.42 Million
≈ $2.42 Million
AU$-283.23K
≈ $-200.40K
-0.083x +76.33%
2019-06-30 AU$3.49 Million
≈ $2.47 Million
AU$-1.22 Million
≈ $-862.86K
-0.350x +0.16%
2018-06-30 AU$4.84 Million
≈ $3.43 Million
AU$-1.70 Million
≈ $-1.20 Million
-0.350x -38.97%
2017-06-30 AU$3.78 Million
≈ $2.67 Million
AU$-952.04K
≈ $-673.63K
-0.252x +3.60%
2016-06-30 AU$4.94 Million
≈ $3.49 Million
AU$-1.29 Million
≈ $-913.32K
-0.261x +39.74%
2015-06-30 AU$2.29 Million
≈ $1.62 Million
AU$-992.80K
≈ $-702.47K
-0.434x -16.52%
2014-06-30 AU$3.32 Million
≈ $2.35 Million
AU$-1.24 Million
≈ $-874.36K
-0.372x +9.78%
2013-06-30 AU$2.35 Million
≈ $1.67 Million
AU$-971.58K
≈ $-687.45K
-0.413x +63.38%
2012-06-30 AU$1.47 Million
≈ $1.04 Million
AU$-1.66 Million
≈ $-1.17 Million
-1.127x -60.99%
2011-06-30 AU$3.14 Million
≈ $2.22 Million
AU$-2.19 Million
≈ $-1.55 Million
-0.700x -14.47%
2010-06-30 AU$2.45 Million
≈ $1.73 Million
AU$-1.50 Million
≈ $-1.06 Million
-0.611x -83.86%
2009-06-30 AU$3.06 Million
≈ $2.16 Million
AU$-1.02 Million
≈ $-719.05K
-0.333x +32.24%
2008-06-30 AU$3.41 Million
≈ $2.41 Million
AU$-1.67 Million
≈ $-1.18 Million
-0.491x +17.42%
2007-06-30 AU$5.50 Million
≈ $3.89 Million
AU$-3.27 Million
≈ $-2.31 Million
-0.594x -58.62%
2006-06-30 AU$8.51 Million
≈ $6.02 Million
AU$-3.19 Million
≈ $-2.26 Million
-0.375x -70.02%
2005-06-30 AU$11.75 Million
≈ $8.31 Million
AU$-2.59 Million
≈ $-1.83 Million
-0.220x --

About Uscom Ltd

AU:UCM Australia Medical Devices
Market Cap
$2.21 Million
AU$3.12 Million AUD
Market Cap Rank
#29870 Global
#1751 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.02
All Time High
AU$0.48
About

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure w… Read more